Login / Signup

Outcomes of COVID-19 in Patients with Inflammatory Bowel Disease: Comparison with Household Members and the Role of IBD Medications.

Ali Reza SimaBahar Saberzadeh-ArdestaniHomayoon VahediHafez FakheriFariborz Mansour-GhanaeiIradj MalekiSiavosh Nasseri-MoghaddamHasan VosoghiniaMohammad Reza GhadirAhmad HormatiAmir KasaeianAmir Reza RadmardBardia KhosraviMasoud MalekzadehSudabeh AlatabAnahita SadeghiNayyereh AminisaniHossein PoustchiElnaz GonoudiAmir AnushiravaniMaryam RayatpishehJean-Frederic ColombelRyan C UngaroFatemeh Malekzadeh
Published in: Archives of Iranian medicine (2022)
Age, presence of new gastrointestinal symptoms and use of 5-ASA were associated with increased hospitalization rate among IBD patients, while anti-TNF therapy had no statistical association.
Keyphrases